Cooperative Agreement W81XWH2120046

Award Date 10/1/21
Completion Date 9/30/23
Dollars Obligated $3.5M
Federal Grant Program
12.350
Assistance Type
Cooperative Agreement
Place of Performance
San Francisco, CA 94104, USA
Similar Awards
The Defense Health Agency awarded Jhpiego Corporation $933,052 under a Cooperative Agreement from October 1, 2021 to September 30, 2023 to support the Department of Defense HIV/AIDS Prevention Program. As part of this award, Jhpiego will provide reproductive, maternal, newborn, child, and adolescent health services, family health and nutrition activities, voluntary medical male circumcision and pre-exposure prophylaxis services, and health system performance improvement efforts to the Botswana...
This $712,771 Cooperative Agreement award from the Defense Health Agency (DHA) under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) supports Labyrinth Global Health, Inc., a woman-owned small business, in implementing a partnership for sustainable HIV epidemic control with the Republic of Sierra Leone Armed Forces. The project aims to provide technical assistance, prevention, care, and treatment services to address HIV/AIDS within the Sierra Leonean military and their...
The U.S. Department of Health and Human Services, Centers for Disease Control and Prevention has awarded a $42,680,510 Cooperative Agreement under the Global AIDS (CFDA 93.067) program to the Shwari Health Association in Cameroon. The purpose of this 5-year award, with a period of performance from September 30, 2024 to September 29, 2029, is to sustain advanced facility and community-based HIV cascade activities in Cameroon. The key products and services to be delivered include strengthening...
The Defense Health Agency awarded a $39,584,124.34 Cooperative Agreement to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program (CFDA 19.029). The five-year award, effective October 1, 2024, supports a global HIV prevention and treatment initiative focused on high-risk and vulnerable populations, including adolescents, key populations, and people living with HIV in various African countries. The...
The Department of Defense HIV/AIDS Prevention Program (DHAPP), with a CFDA number of 12.350, awarded a $184,767.82 cooperative agreement to Alliance Nationale Contre LE Sida in Senegal on September 30, 2024. The award, which runs through September 29, 2025, supports the organization's efforts to provide technical assistance, prevention, care, and treatment services to military personnel and their dependents in Senegal to address HIV/AIDS within the foreign military population. The cooperative...
The federal Cooperative Agreement award ID HT94252420014, valued at $1,955,770.00, was granted by the Defense Health Agency to University Research Co., LLC to implement the "UMBUTFO ESWATINI DEFENCE FORCE (UEDF) PARTNERSHIP FOR SUSTAINABLE HIV EPIDEMIC CONTROL" project. This award is funded under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350), which aims to provide technical assistance, prevention, care, and treatment services to military personnel and their...
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $4,838,896 Cooperative Agreement under the Global AIDS Program (CFDA 93.067) to the Cameroon Baptist Convention Health Board (CBCHB) to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon. The award period runs from September 30, 2024, to October 24, 2024. CBCHB, a non-profit...
This Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $305,352.20 to Population Services International (PSI) to implement the "GUATEMALA, EL SALVADOR, AND HONDURAS: DHAPP CENTRAL AMERICAN ARMED FORCES PARTNERSHIP FOR SUSTAINABLE HIP EPIDEMIC CONTROL" project. The award, effective from September 30, 2024 to September 29, 2025, will support technical assistance, capacity building, and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $15,221,142 five-year Cooperative Agreement under the Global AIDS (CFDA 93.067) program to the Association Camerounaise Pour Le Marketing Social (ACMS) in Cameroon. The grant, which runs from September 30, 2024 to September 29, 2029, aims to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon under the...
The Defense Health Agency awarded a $272,000 cooperative agreement to Liga Colombiana De Lucha Contra El Sida to provide technical support for the management of Colombia's national response to sexually transmitted infections and HIV/AIDS with an emphasis on combined prevention for the military forces and national police from September 30, 2021 through September 29, 2022. The award supports the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350), which provides training and assistance...

Metabiota, Inc. was awarded a $3.5 million cooperative agreement from the Defense Health Agency under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) for the period of October 1, 2021 through September 30, 2023. The award will support Metabiota's efforts to build HIV epidemic control in Cameroon through strengthening HIV prevention, testing, linkage to care and treatment, and viral suppression programs within the Cameroon Defense Force. As part of this cooperative agreement, Metabiota will provide technical assistance and training to help the Cameroon military establish and implement effective HIV/AIDS prevention, care, and treatment programs to benefit military personnel and their dependents. The funding will also aid Metabiota's work with the Cameroon Defense Force on HIV program monitoring and evaluation.

Generated 1/6/24, 3:56 PM